Background Wide-ranging prevalence estimates of psoriatic arthritis (PsA) in patients with
psoriasis have been reported. Objectives To assess the prevalence and incidence of PsA in …

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with
awareness and attention to comorbidities - ScienceDirect Skip to main contentSkip to article …

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting 3% of the
world's population, and approximately one-third of patients with psoriasis will eventually …

Whereas the cellular and molecular features of human inflammatory skin diseases are well
characterized, their tissue context and systemic impact remain poorly understood. We thus …

Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease
characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and …

Psoriatic arthritis (PsA) is a heterogenous, chronic, inflammatory musculoskeletal disease
that can lead to peripheral and axial damage and loss of function. Axial involvement occurs …

Background Prompt identification and treatment of psoriatic arthritis (PsA) in patients with
psoriasis is critical to reducing the risk of joint damage, disability, and comorbidities …

Psoriatic arthritis (PsA) is a chronic, progressive musculoskeletal disease that affects 0.1%–
1% of the general population and~ 20% of patients with psoriasis. Significant differences …

Objective To determine the incidence of depression, anxiety, and suicidality in patients with
psoriasis compared with the general population. Design A population-based cohort study …

The human immune system involves highly complex and coordinated processes in which
small proteins named cytokines play a key role. Cytokines have been implicated in the …